44 Wealth Management LLC lessened its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,551 shares of the company’s stock after selling 827 shares during the period. 44 Wealth Management LLC’s holdings in Clorox were worth $1,226,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new stake in shares of Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its stake in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the period. Asset Planning Inc bought a new stake in shares of Clorox during the fourth quarter valued at approximately $32,000. Finally, Catalyst Capital Advisors LLC acquired a new position in Clorox during the third quarter worth $54,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Clorox Stock Up 2.8 %
Shares of Clorox stock opened at $157.41 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a market cap of $19.39 billion, a P/E ratio of 43.01, a PEG ratio of 2.58 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The firm’s 50 day moving average price is $157.87 and its 200-day moving average price is $159.63.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on the stock. Wells Fargo & Company lifted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. JPMorgan Chase & Co. lifted their price target on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research report on Tuesday, February 4th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Finally, Barclays boosted their price objective on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $158.21.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Energy and Oil Stocks Explained
- MarketBeat Week in Review – 02/17 – 02/21
- 3 Dividend Kings To Consider
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.